Horm Metab Res 1985; 17(12): 667-670
DOI: 10.1055/s-2007-1013639
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Glucagon Administration Induces Lowering of Serum T3 and Rise in Reverse T3 in Euthyroid Healthy Subjects

U. M. Kabadi1 , B. N. Premachandra
  • University of Iowa College of Medicine, Department of Internal Medicine, Iowa City, Iowa, and VA Medical Center, Endocrine Research, Laboratory, St. Louis, Missouri, and Washington University School of Medicine, St. Louis, Missouri, U.S.A.
  • 1VA Medical Center, Medical Service, Des Moines, Iowa, U.S.A.
Further Information

Publication History

1984

1984

Publication Date:
14 March 2008 (online)

Summary

Euthyroid sick syndrome is characterized by low serum T3 and raised reverse T3 (rT3). Most of the states with this syndrome are also documented to manifest hyperglucagonemia. Furthermore, several recent studies have suggested that glucagon may play a role in T4 monodeiodination in some of these states such as starvation and uncontrolled diabetes mellitus. Therefore, hyperglucagonemia was induced by intravenous glucagon administration in euthyroid healthy volunteers and thyroid hormone levels were determined at frequent intervals up to six hours. Plasma glucose and insulin rose promptly on glucagon administration, thus establishing the physiologic effect of glucagon. Serum T4, free T4, T3 resin uptake, and TSH concentrations remained unaltered throughout the study period. Serum T3 declined to a significantly low level (P < 0.05) between 60-90 minutes. Serum rT3 rose significantly (P < 0.05) by four hours and the rise was progressive till the end of the study period. Therefore, these results suggest that hyperglucagonemia may be one of the factors responsible for lowering of T3 and a rise in rT3 in euthyroid sick syndrome.

    >